Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07151950 · ClinicalTrials.gov registry record

Obi Medical Robot: Evaluating Effectiveness Related to Usability

A clinical trial of Rett Syndrome and Cerebral Palsy (CP), sponsored by Desin.

Active
Registry status
50
Enrollment target
1
Study location

NCT07151950: Active study of Rett Syndrome and Cerebral Palsy (CP), sponsored by Desin.

NCT07151950 is a study of Rett Syndrome and Cerebral Palsy (CP) that is active but no longer recruiting, run by Desin. The registered enrollment target is 50 participants, below the 523-participant average among 18 other Rett Syndrome trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07151950, a study of Rett Syndrome and Cerebral Palsy (CP), is active but no longer recruiting, sponsored by Desin.

ACTIVE NOT RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

This mixed-methods usability study evaluates the effectiveness of the Obi Gen 3 robotic feeding device in meeting user needs among providers, caregivers, and patients. Participants will complete a one-week trial using Obi in home, school, or community settings, followed by feedback surveys and optional interviews. The study seeks to validate that the device design meets usability requirements prior to broader deployment.

Primary Outcome

The System Usability Scale (SUS) is a widely used, reliable tool for measuring the usability of a product or system. It consists of a 10-item questionnaire with a five-point Likert scale ranging from "Strongly Disagree" to "Strongly Agree." SUS provides a single score on a scale from 0 to 100 that reflects the overall ease of use and user satisfaction. Developed by John Brooke in 1986, the SUS is technology-agnostic and can be applied across a wide range of systems, including software, websites,

Conditions Studied

Rett Syndrome Cerebral Palsy (CP) ALS (Amyotrophic Lateral Sclerosis) Upper Extremity Impairments

Interventions

  • DEVICE One-week trial of Obi Medical device, which provides robotic assistance with feeding to persons with upper extremity impairments who are unable to self-feed in the traditional manner using utensils

Study Locations (1)

Florida

  • Desin, Llc - Jacksonville

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-05-10
Est. Completion 2025-10-31
Desin

1 total trials

What the registry record for NCT07151950 still lists

NCT07151950 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 523-participant average among 18 other Rett Syndrome trials with a reported enrollment target (90% lower).

The record links to 4 conditions, with Rett Syndrome appearing as the primary indexed condition, and to 1 intervention - of which One-week trial of Obi Medical device, which provides robotic assistance with feeding to persons with upper extremity impairments who are unable to self-feed in the traditional manner using utensils is the first listed.

NCT07151950 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT07151950 about?

NCT07151950 is a clinical study titled "Obi Medical Robot: Evaluating Effectiveness Related to Usability". This mixed-methods usability study evaluates the effectiveness of the Obi Gen 3 robotic feeding device in meeting user needs among providers, caregivers, and patients. Participants will complete a one-week trial using Obi in home, school, or community settings, followed by feedback surveys and optio...

What is the current status of trial NCT07151950?

This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2025-05-10. Estimated completion is 2025-10-31.

What conditions does trial NCT07151950 study?

This clinical trial studies the following conditions: Rett Syndrome, Cerebral Palsy (CP), ALS (Amyotrophic Lateral Sclerosis), Upper Extremity Impairments.

What interventions are being tested in trial NCT07151950?

The interventions under investigation include: One-week trial of Obi Medical device, which provides robotic assistance with feeding to persons with upper extremity impairments who are unable to self-feed in the traditional manner using utensils (DEVICE).

Who is sponsoring clinical trial NCT07151950?

This trial is sponsored by Desin, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07151950 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rett Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07151950's enrollment target sits among peer trials

50 10th of 18 higher than 9 of 18 other Rett Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rett Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT07151950, the US trial registry maintained by the National Library of Medicine. NCT07151950 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.